Search Results for: as

masitinib mesylate

The orally bioavailable mesylate salt of masatinib, a multi-targeted protein tyrosine kinase inhibitor with potential antineoplastic activity. Masitinib … [Read more...]

PI3K / mTOR kinase inhibitor PF-04691502

An agent targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway, with potential … [Read more...]

Polo-like kinase 1 inhibitor ON 01910.Na

A synthetic benzyl styryl sulfone analogue with potential antineoplastic activity. Polo-like kinase 1 inhibitor ON 01910.Na inhibits polo-like kinase1 (Plk1), … [Read more...]

pan HER / VEGFR2 receptor tyrosine kinase inhibitor BMS-690154

A pyrrolotriazine-based compound and a pan inhibitor of receptor tyrosine kinases with potential antineoplastic activity. Pan HER/VEGFR2 receptor tyrosine … [Read more...]

Polo-like kinase 1 inhibitor GSK-461364

A small molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity. Polo-like kinase 1 inhibitor GSK461364 selectively inhibits Plk1, … [Read more...]

Polo-like kinase 1 inhibitor BI 6727

A dihydropteridinone Polo-like kinase 1 (Plk1) inhibitor with potential antineoplastic activity. Polo-like kinase 1 inhibitor BI 6727 selectively inhibits Plk1, … [Read more...]

pTVG-HP plasmid DNA vaccine

A cancer vaccine containing plasmid DNA encoding human prostatic acid phosphatase (PAP) (pTVG-HP) with potential immunostimulatory and antineoplastic … [Read more...]

Modrastane

(Other name for: trilostane) … [Read more...]

Polo-like kinase 1 inhibitor NMS-1286937

An orally bioavailable, small-molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity. Polo-like kinase 1 inhibitor NMS-1286937 … [Read more...]

Metastron

(Other name for: strontium chloride Sr 89) … [Read more...]